- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05704686
Clinical Outcomes of an New EDOF IOL (Isopure®)
Visual Outcomes and Patient Satisfaction After the Implantation of Isopure Extended-Depth-of-Focus Intraocular Lens (EDOF-IOL), With a Mini-Monovision Target
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This single-center retrospective study investigates visual outcomes and patient satisfaction in subjects bilaterally implanted with Enhanced-Depth of Focus (EDOF) Isopure® IOL during routine bilateral cataract surgery.
The study is carried out in an ophthalmic clinic in Switzerland. In this study, routine surgical techniques and postoperative follow-up will be applied as for all other (non-study) cataract patients in the clinic. Therefore, all study patients will be operated in immediate consecutive bilateral mode (routine in clinic). Patients participating in this study will be recruited and enrolled postoperatively. They undergo routine postoperative follow-up examinations, and data are collected at the third scheduled examination (4 to 6 weeks after surgery) and at a telephone call 4 to 6 months after surgery.
Isopure 1.2.3 is a CE certified intraocular lens readily available on the market in Switzerland.
The primary outcome consists in demonstrating a preserved distance visual acuity while improving binocular spectacle-free intermediate vision and, to a lesser extent, near vision. Binocular defocus curves are measured for each participant to simulate visual acuity at different distances. Patient satisfaction with treatment and subjective ratings of visual phenomena will be assessed using a modified PRISQ questionnaire and a modified NEI quality of vision questionnaire (RQL-42) at the third postoperative visit and three months after surgery.
At Vista Alpina Eye Clinic, mini-monovision is routinely used to further improve binocular intermediate and near vision while preserving the quality of distance vision in patients implanted bilaterally with EDOF Isopure® IOLs. Analysis of the retrospective data should help support this surgical strategy.
Patients with astigmatism up to 1.5 D benefit intraoperatively from Opposite Clear Corneal Incisions (OCCI) to reduce astigmatism. Analysis of our retrospective data will allow comparison of their visual performance with that of patients without astigmatism who did not require an additional OCCI procedure.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Visp, Switzerland, 3930
- Vista Alpina Eye Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male or female patients aged 50 years or older undergoing a routine cataract surgery and benefiting from bilateral IOL implantation with Isopure 1.2.3 IOL;
- Patient's willingness to participate in the study;
- Capacity to understand and sign an informed consent form and comply with examination procedures;
- Cataractous eyes with no vision-impacting comorbidity (estimated visual potential post-surgery 0.2 logMAR or better);
- Regular total corneal astigmatism ≤1.5 D (measured by topography method)
Exclusion Criteria:
- Cooperation difficulties (distance from home, general health conditions, cognitive impairment);
- Subjects with diagnosed extra- or intraocular vision-affecting comorbidities (macular degeneration, glaucoma or other retinal or optic nerve disorders, previous ocular surgeries, amblyopia);
- Patients who previously benefitted from refractive surgery (PRK/LASIK) were included if no refractive surgery-related complications were noted (i.e: ectasia, corneal haze, dry eye);
- History or presence of macular edema;
- Perioperative complications;
- Congenital, uveitic, traumatic or surgically-complicated cataract
- Regular total corneal astigmatism >1.5 dioptres (measured by topography method)
- Irregular cornea, including keratotomy
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
UDVA(m)
Time Frame: 4-6 weeks postoperatively
|
Monocular Uncorrected Distance Visual Acuity
|
4-6 weeks postoperatively
|
CDVA(m)
Time Frame: 4-6 weeks postoperatively
|
Monocular Corrected Distance Visual Acuity
|
4-6 weeks postoperatively
|
UDVA(b)
Time Frame: 4-6 weeks postoperatively
|
Binocular Uncorrected Distance Visual Acuity
|
4-6 weeks postoperatively
|
UIVA
Time Frame: 4-6 weeks postoperatively
|
Binocular Uncorrected Intermediate Visual Acuity (80 cm)
|
4-6 weeks postoperatively
|
UNVA
Time Frame: 4-6 weeks postoperatively
|
Binocular Uncorrected Near Visual Acuity (40 cm)
|
4-6 weeks postoperatively
|
Defocus curve
Time Frame: 4-6 weeks postoperatively
|
Binocular distance-corrected defocus curve analysis simulating visual acuities at different distances.
|
4-6 weeks postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient satisfaction with the visual outcome
Time Frame: 4-6 weeks postoperatively and 4-6 months postoperatively
|
(modified) PRISQ questionnaire
|
4-6 weeks postoperatively and 4-6 months postoperatively
|
Subjective rating of visual phenomena
Time Frame: 4-6 weeks postoperatively and 4-6 months postoperatively
|
(modified) NEI quality of vision questionnaire (RQL-42, questions 17 and 38)
|
4-6 weeks postoperatively and 4-6 months postoperatively
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Impact of OCCI on residual refractive cylinder
Time Frame: 4-6 weeks postoperatively
|
Residual refractive cylinder in eyes undergoing OCCI (eyes with preoperative topographic total corneal astigmatism 0.6 - 1.5 diopters), compared to eyes not having undergone OCCI (preoperative topographic cylinder 0 - 0.5 diopters).
|
4-6 weeks postoperatively
|
Impact of OCCI on uncorrected binocular visual acuity
Time Frame: 4-6 weeks postoperatively
|
Comparison of binocular UDVA between three subgroups.
Subgroup 1: both eyes having undergone OCCI.
Subgroup 2: one eyes having undergone OCCI.
Subgroup 3: none of the eyes having undergone OCCI.
|
4-6 weeks postoperatively
|
Impact of OCCI on uncorrected monocular visual acuity
Time Frame: 4-6 weeks postoperatively
|
Comparison of monocular UDVA between eyes having undergone OCCI and eyes not having undergone OCCI (eyes with emmetropic objective only)
|
4-6 weeks postoperatively
|
Accuracy of different IOL-formulas
Time Frame: 4-6 weeks postoperatively
|
Comparing various IOL-formulas used to calculate the appropriate IOL power during preoperative assessment.
The objective is to determine which IOL formulas are most accurate, overall, and (subgroups) in function of the anatomy of the eye (short vs long eyes, shallow versus deep anterior chamber)
|
4-6 weeks postoperatively
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kristof Vandekerckhove, MD, Vista Alpina Eye Clinic
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Iso123
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Advanced Center for Eyecare GlobalNot yet recruiting
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruitingCataract ExtractionChina
Clinical Trials on Isopure 1.2.3 intraocular EDOF lens implantation
-
Beaver-Visitec International, Inc.targomedGmbHCompletedCataract | Lens OpacitiesSpain
-
Beaver-Visitec International, Inc.targomedGmbHActive, not recruitingCataract | Lens OpacitiesSpain, Germany, Philippines, Czechia, Austria, Ireland
-
Beaver-Visitec International, Inc.targomedGmbHCompletedCataract | Lens OpacitiesSwitzerland
-
Beaver-Visitec International, Inc.targomedGmbHRecruiting
-
Rabin Medical CenterEinat Medical Inc.UnknownRefractive Error | Corneal Implantation | Intraocular Lens ImplantationIsrael
-
Thomas NagySengiTerminated
-
Universitaire Ziekenhuizen KU LeuvenCompletedCataract | Vitreous DisorderBelgium
-
Loay Abdulmutalib AlmusawiRecruitingSafety and Suitability of ICL for Correction of Refractive Errors Without the Use of Dispersive OVDsRefractive Errors | Myopia | Hypermetropia | Myopic AstigmatismIraq
-
Sunnybrook Health Sciences CentreRecruitingCorneal Endothelial Cell Loss | Secondary Intraocular LensCanada